1998
DOI: 10.1016/s0303-7207(98)00104-x
|View full text |Cite
|
Sign up to set email alerts
|

Procorticotrophin-releasing hormone: endoproteolytic processing and differential release of its derived peptides within AtT20 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

1999
1999
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 44 publications
0
7
0
Order By: Relevance
“…Alternatively, the differential post-translational endoproteolysis of the GnIH precursor might be associated with the physiological functions of GnIH and GnIH-RP-2. Recently, some bioactive peptides originating from one precursor polypeptide have been shown to be differentially processed or sorted into distinct secretory granules [30][31][32][33][34][35], which enables peptides to undergo cell-specific or tissue-specific functional targeting. These findings support a notion that proGnIH might undergo differential proteolytic processing and\or that GnIH and GnIH-RP-2 are packed into different secretory granules for subsequent release into distinct target tissues.…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, the differential post-translational endoproteolysis of the GnIH precursor might be associated with the physiological functions of GnIH and GnIH-RP-2. Recently, some bioactive peptides originating from one precursor polypeptide have been shown to be differentially processed or sorted into distinct secretory granules [30][31][32][33][34][35], which enables peptides to undergo cell-specific or tissue-specific functional targeting. These findings support a notion that proGnIH might undergo differential proteolytic processing and\or that GnIH and GnIH-RP-2 are packed into different secretory granules for subsequent release into distinct target tissues.…”
Section: Discussionmentioning
confidence: 99%
“…Pre-proCRH is cleaved in the rough endoplasmic reticulum to generate proCRH with a molecular mass of 18 kDa, which increases to 23 kDa after post-translational modifications (29,37). Pro-CRH undergoes endoproteolytic processing within the trans-Golgi network and secretory granules that appears to be controlled by the convertases PC1 and PC2 to generate the final 41 aa residue (4.7 kDa) CRH peptide (29,37,38). Expression of the CRH gene is controlled by a promoter region located ϳ200 bp upstream that contains the TATA box and cyclic AMP-responsive element (CRE) (29 -31).…”
Section: Overview Of Corticotropin-releasing Hormone (Crh) and Urocormentioning
confidence: 99%
“…The proteolytic processing of many prohormones by prohormone convertases-1/3 (PC1/3) also begins in the TGN (3). Prohormones initially cleaved in the TGN include prothyrotropin-releasing hormone (pro-TRH) (7), prosomatostatin (8), proneurotensin-neuromendin-N (9), procorticotrophin-releasing factor (10), and pro-opiomelanocortin (11)(12)(13), although some cases are controversial (14,15). Thus, we hypothesized that peptides derived from post-translational processing of a given precursor could be differentially sorted within the secretory pathway if the proteolytic processing occurs before to the sorting events.…”
mentioning
confidence: 99%